Log in

LON:VCTVictrex Share Price, Forecast & News

GBX 2,080
+2.00 (+0.10 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
2,050.41
Now: GBX 2,080
2,132
50-Day Range
1,893
MA: GBX 1,994.68
2,090
52-Week Range
1,645
Now: GBX 2,080
2,574
Volume186,813 shs
Average Volume274,177 shs
Market Capitalization£1.80 billion
P/E Ratio20.17
Dividend Yield3.02%
BetaN/A
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Read More
Victrex logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.9Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.09 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1253-897700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£299.80 million
Cash FlowGBX 63.87 per share
Book ValueGBX 542.10 per share

Profitability

Miscellaneous

Employees921
Market Cap£1.80 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive VCT News and Ratings via Email

Sign-up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter.

Victrex (LON:VCT) Frequently Asked Questions

How has Victrex's stock been impacted by COVID-19 (Coronavirus)?

Victrex's stock was trading at GBX 1,952 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VCT shares have increased by 6.6% and is now trading at GBX 2,080. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Victrex?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Victrex in the last year. There are currently 4 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Victrex.

How were Victrex's earnings last quarter?

Victrex plc (LON:VCT) released its earnings results on Monday, May, 11th. The company reported $47.60 earnings per share (EPS) for the quarter. View Victrex's earnings history.

How often does Victrex pay dividends? What is the dividend yield for Victrex?

Victrex declared a dividend on Thursday, December 5th. Investors of record on Thursday, January 30th will be paid a dividend of GBX 46.14 per share on Friday, February 21st. This represents a dividend yield of 1.98%. The ex-dividend date is Thursday, January 30th. This is a boost from Victrex's previous dividend of GBX 13.42. The official announcement can be seen at this link. View Victrex's dividend history.

What price target have analysts set for VCT?

11 analysts have issued 12 month price objectives for Victrex's shares. Their forecasts range from GBX 1,690 to GBX 2,400. On average, they anticipate Victrex's stock price to reach GBX 1,996.82 in the next twelve months. This suggests that the stock has a possible downside of 4.0%. View analysts' price targets for Victrex.

Has Victrex been receiving favorable news coverage?

News coverage about VCT stock has been trending neutral on Saturday, InfoTrie reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Victrex earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutVictrex.

Who are some of Victrex's key competitors?

What other stocks do shareholders of Victrex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Victrex investors own include Anglo American (AAL), Centamin (CEY), Renishaw (RSW), Hastings Group (HSTG), Rotork (ROR), Playtech (PTEC), Spirent Communications (SPT), Ashtead Group (AHT), Rio Tinto (RIO) and Quilter (QLT).

Who are Victrex's key executives?

Victrex's management team includes the following people:
  • Mr. Jakob O. Sigurdsson BA, MBA, CEO & Exec. Director (Age 55)
  • Mr. Richard Armitage, Group Fin. Director & Exec. Director (Age 53)
  • Mr. Timothy J. Cooper, Exec. Director of Industrial & Exec. Director
  • Dr. Martin L. Court, Exec. Director of Medical & Exec. Director (Age 57)
  • Mr. Andrew Hanson, Director of Investor Relations & Corp. Communications

What is Victrex's stock symbol?

Victrex trades on the London Stock Exchange (LON) under the ticker symbol "VCT."

How do I buy shares of Victrex?

Shares of VCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Victrex's stock price today?

One share of VCT stock can currently be purchased for approximately GBX 2,080.

How big of a company is Victrex?

Victrex has a market capitalization of £1.80 billion and generates £299.80 million in revenue each year. Victrex employs 921 workers across the globe.

What is Victrex's official website?

The official website for Victrex is www.victrexplc.com.

How can I contact Victrex?

Victrex's mailing address is Victrex Technology Centre , Hillhouse International,, THORNTON CLEVELEYS, FY5 4QD, United Kingdom. The company can be reached via phone at +44-1253-897700.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.